TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval September 18, 1998
TCL Archive Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial. June 15, 2007